nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A 50-gene signature is a novel scoring system for tumor-infiltrating immune cells with strong correlation with clinical outcome of stage I/II non-small cell lung cancer
|
Hernández-Prieto, S. |
|
2014 |
17 |
4 |
p. 330-338 |
artikel |
2 |
A 50-gene signature is a novel scoring system for tumor-infiltrating immune cells with strong correlation with clinical outcome of stage I/II non-small cell lung cancer
|
Hernández-Prieto, S. |
|
|
17 |
4 |
p. 330-338 |
artikel |
3 |
Analysis of regulatory T cells frequency in peripheral blood and tumor tissues in papillary thyroid carcinoma with and without Hashimoto’s thyroiditis
|
Liu, Y. |
|
2014 |
17 |
4 |
p. 274-280 |
artikel |
4 |
A study comparing two consecutive historical periods in breast cancer with a focus on surgical treatment, loco-regional recurrence, distant metastases and mortality
|
García-Fernández, A. |
|
2014 |
17 |
4 |
p. 296-305 |
artikel |
5 |
CC genotype of anti-apoptotic gene BCL-2 (−938 C/A) is an independent prognostic marker of unfavorable clinical outcome in patients with non-small-cell lung cancer
|
Javid, J. |
|
2014 |
17 |
4 |
p. 289-295 |
artikel |
6 |
Gene expression differences in primary colorectal tumors and matched liver metastases: chemotherapy related or tumoral heterogeneity?
|
López-Gómez, M. |
|
2014 |
17 |
4 |
p. 322-329 |
artikel |
7 |
Overexpression of ribonuclease inhibitor defines good prognosis and suppresses proliferation and metastasis in human colorectal cancer cells via PI3K/AKT pathway
|
Tang, Y. |
|
2014 |
17 |
4 |
p. 306-313 |
artikel |
8 |
Preventive treatments for breast cancer: recent developments
|
Alés-Martínez, J. E. |
|
2014 |
17 |
4 |
p. 257-263 |
artikel |
9 |
Quantification of circulating endothelial cells as a predictor of response to chemotherapy with platinum and pemetrexed in patients with advanced non-squamous non-small cell lung carcinoma
|
Sánchez Hernández, Alfredo |
|
2014 |
17 |
4 |
p. 281-288 |
artikel |
10 |
Secretory leukocyte protease inhibitor is a proliferation and survival factor for pancreatic cancer cells
|
Zuo, J. |
|
2014 |
17 |
4 |
p. 314-321 |
artikel |
11 |
Updated guidelines for biomarker testing in colorectal carcinoma: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
|
García-Alfonso, P. |
|
2014 |
17 |
4 |
p. 264-273 |
artikel |